Table 1.
Clinical, immunological, and virological parameters of an HIV-1-leprosy coinfected patient in western Kenya.
| EVENT | Weight (kg) | CD4 count (Cells/mL) | CD4% | Plasma viral load (copies/mL) |
|---|---|---|---|---|
| Enrolment | 65 | 145 | 10 | |
| ART initiated 1 month later | ||||
| 5 months* | 66 | 272 | 16 | |
| 12 months* | 64 | 154 | 13 | |
| 15 months* | 65 | 152 | 13 | |
| 23 months* | 62 | 192 | 11 | |
| 27 months* | 58 | 110 | 8 | |
| 29 months* | 1,084,798 | |||
| 32 months* | 62 | 169 | 11 | |
| 35 months * | 433,376 | |||
| 40 months* | 60 | 155 | 13 | |
| 45 months* | 55 | 195 | 7 | |
| 47 months: Switch to second-line ART | ||||
| 6 months** | 60 | 320 | 11 | |
| 7 months** | Started antileprosy chemotherapy | |||
| 13 months** | 188 | |||
*After ART initiation.
**After initiation of second-line ART.